Victoria Whyte - GlaxoSmithKline plc Insider

GSK -- USA Stock  

USD 41.74  0.01  0.024%

Company Secretary
Ms. Victoria L. Whyte serves as Company Secretary of GlaxoSmithKline PLC., since 1 January 2011. She is a solicitor and a Fellow of the Institute of Chartered Secretaries and Administrators. Victoria was formerly Deputy Secretary and Secretary to the Remuneration Committee. She has acted as Secretary to the Board and all the Boards Committees since her appointment as Company Secretary on 1 January 2011.
  Executive Since 2011      
44 20 8047 5000  http://www.gsk.com

Management Efficiency

The company has Return on Asset of 7.36 % which means that on every $100 spent on asset it made $7.36 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 37.13 % implying that it generated $37.13 on every 100 dollars invested.
The company has 23.08 B in debt with debt to equity (D/E) ratio of 486.2 . This implies that the company may be unable to create cash to meet all of its financial commitments. GlaxoSmithKline plc has Current Ratio of 0.6 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.

Similar Executives

Entity Summary

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GlaxoSmithKline plc is traded on New York Stock Exchange in USA.GlaxoSmithKline plc (GSK) is traded on New York Stock Exchange in USA. It is located in UNITED KINGDOM and employs 98,462 people. GlaxoSmithKline plc is listed under Pharmaceutical Products category by Fama And French industry classification.

GlaxoSmithKline plc Leadership Team

Vindi Banga, Director
Lynn Elsenhans, Director
Luke Miels, President, MBA
Hal Barron, President, Ph.D
Daniel Podolsky, Director
Emma Walmsley, President
Luc Debruyne, President
Andrew Witty, CEO, MBA
Brian McNamara, CEO, MBA
Roy Anderson, Director
Philip Hampton, Director
Simon Dingemans, Director
Vivienne Cox, Director, Ph.D
Bill Louv, President
Roger Connor, President
Abbas Hussain, President
Phil Thomson, President
Judy Lewent, Director
Hans Wijers, Director
Stephanie Burns, Director, Ph.D
Moncef Slaoui, Chairman, Ph.D
Urs Rohner, Director
Deryck Maughan, Director
Jesse Goodman, Director, Ph.D
Laurie Glimcher, Director
Nick Hirons, President
Victoria Whyte, Executive
Daniel Troy, SVP
Shah Hussain, President
Manvinder Banga, Director
David Redfern, Executive
Patrick Vallance, President
Stacey Cartwright, Director
Karenann Terrell, Executive
Claire Thomas, SVP

Stock Performance Indicators

Current Sentiment - GSK

GlaxoSmithKline plc Investor Sentiment
Predominant part of Macroaxis users are currently bullish on GlaxoSmithKline plc. What is your judgment towards investing in GlaxoSmithKline plc? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.